CCCR [Bat] 8-K: (Original Filing)

[CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF BAT GROUP, INC. State of Delaware Secretary of State Division of Corporations Delivered 12:04 PM 03/06/2020 FILED 12:04 PM 03/06/2020 SR 20201970728 - Adopted in accordance with the provisions of Section 242 of the General Corporation Law o]

By | 2020-10-01T16:50:19+00:00 March 12th, 2020|Categories: CCCR, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

CLNT [SHARING ECONOMY INTERNATIONAL] 8-K: (Original Filing)

[SHARE EXCHANGE AGREEMENT Annex A THIS SHARE EXCHANGE AGREEMENT (the “Agreement”) dated as of March 11, 2020, is entered into by and among Sharing Economy International Inc., a Nevada corporation (“Sharing Economy”), and Jebe Production Group Limited, a Hong Kong corporation (“Jebe Production”), and ]

IDI [Fluent] 8-K: Fluent Announces Fourth Quarter and Full-Year 2019 Financial

[Fluent Announces Fourth Quarter and Full-Year 2019 Financial Results • $80.0 13% Q4 2019 revenue of • $1.0 $0.01 Net income from continuing operations of • $26.3 5% 32.9% Media margin of • $11.5 14% Adjusted EBITDA of • $6.1 $0.08 Adjusted net income of New York, NY – March 12, 2020 Ryan Schulke, Fl]

By | 2020-10-01T16:34:46+00:00 March 12th, 2020|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)

[001-31914 中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME Reference is made to the Company’s announcement dated 27 August 2004. The accumulated pr]

By | 2020-10-01T13:13:21+00:00 March 12th, 2020|Categories: Chinese Stocks, LFC, SEC Original|Tags: , , , , , |0 Comments

CYOU [Changyou.com] SC 13G/A: (Original Filing)

[CHANGYOU.COM LIMITED (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) 15911M107 (CUSIP Number) 10 March 2020 (Date of Event which Requires Filing of this Statement) [_] Rule 13d-1(b) [x] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for ]

By | 2020-10-01T08:13:41+00:00 March 11th, 2020|Categories: Chinese Stocks, CYOU, SEC Original|Tags: , , , , , |0 Comments

CCM [Concord Medical Services] 6-K: (Original Filing)

[Concord Medical Welcomes RMB700 Million Investment As the most important operating platform of Concord Medical in China, Meizhong Jiahe is focusing on the development and management of comprehensive cancer hospitals and the standalone radiotherapy and diagnostic imaging center network in China. Meiz]

CYOU [Changyou.com] SC 13G/A: CHANGYOU.COM LIMITED (Name of Issuer) Class A Ordinary

[CHANGYOU.COM LIMITED (Name of Issuer) Class A Ordinary Shares (Title of Class of Securities) 15911M107 (CUSIP Number) 10 March 2020 (Date of Event which Requires Filing of this Statement) [_] Rule 13d-1(b) [x] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for ]

By | 2020-10-01T08:13:45+00:00 March 11th, 2020|Categories: Chinese Stocks, CYOU, Webplus ver|Tags: , , , , , |0 Comments

CCM [Concord Medical Services] 6-K: Concord Medical Welcomes RMB700 Million Investment As the

[Concord Medical Welcomes RMB700 Million Investment As the most important operating platform of Concord Medical in China, Meizhong Jiahe is focusing on the development and management of comprehensive cancer hospitals and the standalone radiotherapy and diagnostic imaging center network in China. Meiz]

CO [Global Cord Blood] 6-K: Global Cord Blood Corporation Reports Financial Results for

[Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020 3Q20 Added 23,387 New Subscribers Revenues Up 31.7% YoY to RMB334.7 Million ($48.1 Million) Operating Income Up 65.1% YoY to RMB152.9 Million ($22.0 Million) Non-GAAP Operating Income U]

By | 2020-10-01T15:43:03+00:00 March 11th, 2020|Categories: Chinese Stocks, Webplus ver|Tags: , , , , |0 Comments

CO [Global Cord Blood] 6-K: (Original Filing)

[Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020 3Q20 Added 23,387 New Subscribers Revenues Up 31.7% YoY to RMB334.7 Million ($48.1 Million) Operating Income Up 65.1% YoY to RMB152.9 Million ($22.0 Million) Non-GAAP Operating Income U]

By | 2020-10-01T15:42:58+00:00 March 11th, 2020|Categories: Chinese Stocks, SEC Original|Tags: , , , , |0 Comments
Skip to toolbar